Dew, let me guess: Bristol and Imclone sue each other, perhaps with the latter occurring after Bristol attempts to 'sandbag' the NSCLC sBLA (the key to a rapid near-term rise in the share valuation is still likely the lung indication, possibly already occurring if the off-label use there is indeed already increasing rapidly)....and the shareholders sue both boards as well as Carl individually. What a potential mess! (All speculation, of course.)
Make you a deal: I'll promise to refrain from litigation if you will promise such too!...Do we have a litiginous society, or what?!
Best regards,
rjurko (Bob)
